when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

NOVO · news · pharmadog

← back to NOVO

News mentioning NOVO

165 stories

22dThe data that led Cellular Intelligence to pick up Novo's Parkinson's stem cell therapyendpoints

23dCatalent to divest UK site; Rottendorf, Evonik announce manufacturing buildsendpoints

23dOpinion: Who benefits from classifying obesity as a disease?stat

24dSTAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and morestat

24dKailera says obesity pill succeeds in late-stage trial in Chinabiopharma dive

25dSTAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and morestat

26dNovartis to acquire ADC developer in a deal worth up to $1.5Bbiopharma dive

26dSTAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and morestat

29dSTAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitalsstat

29dSTAT+: Up and down the ladder: The latest comings and goingsstat

Jul 2, 26STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and morestat

Jul 2, 26The new presidential fitness test is a positive step, not the solution, experts saystat

Jul 1, 26STAT+: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenesstat

Jun 30, 26Republican Tom Kean Jr. reveals depression diagnosis after his four-month absence from Congressstat

Jun 30, 26Half of states sue over Medicaid work requirementsstat

Jun 30, 26STAT+: Even with MAHA, Trump administration has gone soft on alcoholstat

Jun 30, 26STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordiskstat

Jun 29, 265 takeaways from STAT’s investigation into microhospital operator Nutex Healthstat

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 20, 26Biopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and moreendpoints

Jun 19, 26STAT+: Up and down the ladder: The latest comings and goingsstat

Jun 18, 26STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims datastat

Jun 18, 26STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims datastat

Jun 18, 26cAMPfield lands $180M to build gut disease drugbiopharma dive

Jun 18, 26Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50Mendpoints

Jun 18, 26STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and morestat

Jun 18, 26Novocure’s electric fields therapy fails key glioblastoma studyendpoints

Jun 18, 26What’s next for GLP-1 weight loss drugs?stat

Jun 17, 26FTC, four state AGs sue transgender health group over care standardsstat

Jun 17, 26NIH diversity programs doubled undergraduates’ odds of getting a Ph.D., 20-year study findsstat

← prevpage 3 of 6next →